ClinicalTrials.Veeva

Menu

Burden of Invasive Group B Streptococcal Disease in Infants and Resistance Surveillance in China

H

Health Science Center of Xi'an Jiaotong University

Status

Unknown

Conditions

Invasive Group B Streptococcal Disease

Study type

Observational

Funder types

Other

Identifiers

NCT02812576
XJTU-CDSP_01

Details and patient eligibility

About

Data on neonatal GBS disease are very limited in China. Acceptance and implementation of prevention measures such as antibiotics prevention or vaccination against GBS disease would require robust data. This study as the first national, multicenter study to investigate the epidemiology of GBS disease in China, and the resistance surveillance of GBS isolates, to appraise the necessity of appropriate interventions.

Enrollment

150 estimated patients

Sex

All

Ages

Under 90 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Positive culture for GBS from normally sterile sites such as blood or cerebrospinal fluid.
  2. ≤90 days old at the time of GBS confirmation.
  3. Voluntary written informed consent provided.

Exclusion criteria

  1. None

Trial contacts and locations

1

Loading...

Central trial contact

Wenjing Ji, MS; Yu Fang, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems